INSM News and Press, Insmed Inc. From 03/27/24

Insmed to Present New Data from Across its Respiratory Portfolio at the American Thoracic Society 2024 International Conference PR Newswire — Additional Data from ARISE Study Evaluating the Impact of ARIKAYCE on Microbiologic Outcomes in Patients with Newly Diagnosed or...

Insmed To Present at Three March Conferences PR Newswire BRIDGEWATER, N.J. , Feb. 29, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today ...

Actress Jane Seymour and Insmed Raise Awareness of "Unseenism" and Empower People to Speak Up When It Comes to Their Health PR Newswire — New survey reveals the prevalence of "Unseenism," which can be described as a social phenomenon where gender and age biases can leav...

2024-02-22 13:00:04 ET Insmed Incorporated (INSM) Q4 2023 Earnings Conference Call February 22, 2024 8:30 AM ET Company Participants Bryan Dunn – Head-Investor Relations Will Lewis – Chairman and Chief Executive Officer Sara Bonstein – Chief ...

2024-02-21 12:12:01 ET More on Insmed JP Morgan bullish on six Big Biotechs, rates nine others neutral or lower Seeking Alpha’s Quant Rating on Insmed Historical earnings data for Insmed Financial information for Insmed Read the full article ...

2024-02-15 11:35:43 ET Summary Liquidia Corporation shares rallied over 80% after an appeals court invalidated the patent of rival United Therapeutics, potentially paving the way for approval of its PAH and PH-ILD medication Yutrepia. However, the FDA recently extended the origina...

2024-02-13 11:26:18 ET More on AN2 Therapeutics Biggest stock movers today: Diamondback Energy, Joby Aviation, monday.com, and more AN2 Therapeutics plunges after pause on pivotal trial Seeking Alpha’s Quant Rating on AN2 Therapeutics Historical earnin...

Insmed to Host Fourth-Quarter and Full Year 2023 Financial Results Conference Call on Thursday, February 22, 2024 PR Newswire BRIDGEWATER, N.J. , Feb. 8, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to tr...

2024-01-09 04:54:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Insmed Provides Business Update at 42nd Annual J.P. Morgan Healthcare Conference PR Newswire —ARIKAYCE ® (amikacin liposome inhalation suspension) Delivers Full-Year 2023 Revenues Exceeding the Upper End of Guidance Range with Unaudited Global Net Product Sales o...